4.7 Review

Pulmonary Rehabilitation and Asthma

期刊

FRONTIERS IN PHARMACOLOGY
卷 11, 期 -, 页码 -

出版社

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2020.00542

关键词

pulmonary rehabilitation; asthma; exercise training; chronic disease; treatment

向作者/读者索取更多资源

Asthma is a chronic inflammatory disease characterized by airflow limitation and variable respiratory symptoms. It is characterized by variable symptoms such as cough, wheeze, chest tightness, and shortness of breath which vary in intensity and time. In order to reach a comprehensive approach of disease management, the importance of non-pharmacological treatment in addition to pharmacological therapy has been recently highlighted. Studies have documented that pulmonary rehabilitation has beneficial effects in patients with asthma, at any stage of the disease, improving exercise capacity, asthma control, and quality of life and reducing wheezing, anxiety, depression, and bronchial inflammation. Although several evidences suggest a role of pulmonary rehabilitation in patients with asthma, additional information is required to identify a specific program in order to improve clinical care based on specific patient's needs.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Respiratory System

A snapshot of exhaled nitric oxide and asthma characteristics: experience from high to low income countries

Patrizia Pignatti, Dina Visca, Stelios Loukides, Anne -Grete Martson, Jan-Willem C. Alffenaar, Giovanni Battista Migliori, Antonio Spanevello

Summary: This narrative review examines the relationship between fractional nitric oxide (FeNO) and the physiopathologic characteristics of asthmatic patients, as well as the factors affecting FeNO levels and the impact of corticosteroid therapy, target therapies, and rehabilitation programs. The review also discusses the potential of using FeNO as a marker for evaluating airway inflammation and monitoring adherence to inhaled corticosteroid therapy, particularly in low income countries.

PULMONOLOGY (2022)

Letter Respiratory System

The Role of Blood Gas Analysis in the Post-Acute Phase of COVID-19 Pneumonia

Dina Visca, Giovanni Battista Migliori, Anh-Tuan Dinh-Xuan, Rosella Centis, Stefano Belli, Michele Vitacca, Maria Aliani, Elisabetta Zampogna, Davide Feci, Patrizia Pignatti, Martina Zappa, Laura Saderi, Giovanni Sotgiu, Antonio Spanevello

ARCHIVOS DE BRONCONEUMOLOGIA (2022)

Article Critical Care Medicine

The role of small airway dysfunction in asthma control and exacerbations: a longitudinal, observational analysis using data from the ATLANTIS study

Monica Kraft, Matthew Richardson, Brian Hallmark, Dean Billheimer, Maarten Van den Berge, Leonardo M. Fabbri, Thys Van der Molen, Gabriele Nicolini, Alberto Papi, Klaus F. Rabe, Dave Singh, Chris Brightling, Salman Siddiqui

Summary: Small airway disease, as measured by physiological tests, is longitudinally associated with clinically important asthma outcomes, such as asthma control and exacerbations.

LANCET RESPIRATORY MEDICINE (2022)

Article Critical Care Medicine

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study

Tessa M. Kole, Elise Vanden Berghe, Monica Kraft, Judith M. Vonk, Martijn C. Nawijn, Salman Siddiqui, Kai Sun, Leonardo M. Fabbri, Klaus F. Rabe, Kian Fan Chung, Gabriele Nicolini, Alberto Papi, Chris Brightling, Dave Singh, Thys van der Molen, Sven-Erik Dahlen, Alvar Agusti, Rosa Faner, Jadwiga A. Wedzicha, Gavin C. Donaldson, Ian M. Adcock, Lies Lahousse, Huib A. M. Kerstjens, Maarten van den Berge

Summary: This post-hoc analysis investigates the determinants, clinical implications, and outcome of persistent airflow limitation (PAL) in patients with asthma. The study reveals that PAL is not only present in severe asthma, but also in a considerable proportion of patients with milder disease. In patients with mild asthma, PAL is associated with eosinophilic inflammation and a higher risk of exacerbations, suggesting the need for increased treatment intensity.

LANCET RESPIRATORY MEDICINE (2023)

Article Medicine, General & Internal

Airflow grades, outcome measures and response to pulmonary rehabilitation in individuals after an exacerbation of severe chronic obstructive pulmonary disease

Michele Vitacca, Mara Paneroni, Beatrice Salvi, Antonio Spanevello, Piero Ceriana, Claudio Bruschi, Bruno Balbi, Maria Aliani, Nicolino Ambrosino

Summary: This study suggests that the success rate of pulmonary rehabilitation (PR) is not affected by airflow severity and outcome measures in individuals with severe COPD recovering from exacerbation. In addition to the commonly used outcome measures, Barthel dyspnoea index and Short Physical Performance Battery are also sensitive to PR.

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Letter Medicine, General & Internal

The new phase of pandemic: Are BA.2.75 and BQ.1 competitive variants? An in silico evaluation

Martina Zappa, Paolo Verdecchia, Fabio Angeli

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Review Biochemistry & Molecular Biology

mRNA Metabolism and Hypertension

Martina Zappa, Paolo Verdecchia, Antonio Spanevello, Michele Golino, Fabio Angeli

Summary: Hypertension is the most common cardiovascular risk factor worldwide, contributing significantly to the risk of cardiovascular events and death. Despite stable prevalence, the number of hypertensive patients have doubled in the last 30 years, with a low proportion of controlled hypertension. Understanding the pathogenesis of hypertension and modulating RNA metabolism pharmacologically have been explored as potential therapeutic strategies.

BIOMEDICINES (2023)

Review Medicine, General & Internal

Interpretation of Ambulatory Blood Pressure Monitoring for Risk Stratification in Hypertensive Patients: The 'Ambulatory Does Prediction Valid (ADPV)' Approach

Fabio Angeli, Gianpaolo Reboldi, Francesco Giuseppe Solano, Antonietta Prosciutto, Antonella Paolini, Martina Zappa, Claudia Bartolini, Andrea Santucci, Stefano Coiro, Paolo Verdecchia

Summary: Several outcome-based prospective investigations have shown the prognostic value of 24-hour ambulatory blood pressure monitoring in cardiovascular risk stratification. Average 24-hour, daytime, and nighttime blood pressures are essential components that improve risk assessment beyond traditional factors. However, the interpretation and clinical use of ambulatory blood pressure monitoring need standardization, and implementing its results in individual patient management remains challenging.

DIAGNOSTICS (2023)

Letter Medicine, General & Internal

Hypertension and myocarditis following COVID-19 vaccination. Two sides of the coin?

Fabio Angeli, Gianpaolo Reboldi, Martina Zappa, Paolo Verdecchia

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Editorial Material Medicine, General & Internal

Newer COVID-19 vaccines: Still lights and shadows?

Fabio Angeli, Martina Zappa, Paolo Verdecchia

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Letter Medicine, General & Internal

The old and the new: The EG.5 ('Eris') sub-variant of Coronavirus

Martina Zappa, Paolo Verdecchia, Andrea Andolina, Fabio Angeli

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Editorial Material Medicine, General & Internal

Is the competition between variants the end of severe acute respiratory syndrome coronavirus 2 pandemic? A journey from Wuhan to XBB.1.16

Martina Zappa, Paolo Verdecchia, Fabio Angeli

EUROPEAN JOURNAL OF INTERNAL MEDICINE (2023)

Article Respiratory System

European Respiratory Society short guidelines for the use of as-needed ICS/formoterol in mild asthma

Alberto Papi, Diogenes S. Ferreira, Ioana Agache, Eugenio Baraldi, Richard Beasley, Guy Brusselle, Courtney Coleman, Mina Gaga, Carolina Maria Gotera Rivera, Erik Melen, Ian D. Pavord, Deborah Penate Gomez, Daniel Schuermans, Antonio Spanevello, Thomy Tonia, Florence Schleich

Summary: Recent clinical trials have shown that using as-needed ICS/formoterol could be a potential treatment option for mild asthma. The European Respiratory Society's Task Force has provided evidence-based recommendations, suggesting that adults with mild asthma should use as-needed ICS/formoterol instead of regular ICS maintenance treatment plus as-needed SABA, while adolescents can choose either as-needed ICS/formoterol or ICS maintenance treatment plus as-needed SABA.

EUROPEAN RESPIRATORY JOURNAL (2023)

Article Infectious Diseases

Clinical standards for diagnosis, treatment and prevention of post-COVID-19 lung disease

D. Visca, R. Centis, E. Pontali, E. Zampogna, A. -M. Russell, G. B. Migliori, C. Andrejak, M. Aro, H. Bayram, K. Berkani, J. Bruchfeld, J. M. Chakaya, J. Chorostowska-Wynimko, B. Crestani, M. P. Dalcolmo, L. D'Ambrosio, A-T. Dinh-Xuan, S. Duong-Quy, C. Fernandes, J. -M. Garcia-Garcia, A. de Melo Kawassaki, L. Carrozzi, M. A. Martinez-Garcia, P. Carreiro Martins, M. Mirsaeidi, Y. Mohammad, R. N. Naidoo, N. Neuparth, L. Sese, D. R. Silva, I. Solovic, T. M. Sooronbaev, A. Spanevello, N. Sverzellati, L. Tanno, S. Tiberi, T. Vasankari, E. Vasarmidi, M. Vitacca, I. Annesi-Maesano

Summary: This is the first consensus-based set of clinical standards for the diagnosis, treatment, and prevention of post-COVID-19 lung disease. The aim is to improve patient care and quality of life by guiding clinicians, program managers, and public health officers in planning and implementing a pulmonary rehabilitation program to manage post-COVID-19 lung disease.

INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE (2023)

暂无数据